Who has invested in mPharma?

Novastar Ventures, Citi, Lux Capital, JAM Fund are named among the investors backing mPharma.

mPharma Funding: $95M Raised, Series D (2022)

mPharma funding overview

mPharma is based in Accra, Ghana. mPharma has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in January 2022. The round record for mPharma runs through 2022; nothing later has been disclosed. Investors on record include Novastar Ventures, Citi, Lux Capital, JAM Fund. 4 distinct backers are named across the disclosed rounds.

mPharma at a glance

Total raised: $95M
Latest round: Series D
Latest round date: January 2022
Headquarters: Accra, Ghana
Notable investors: Novastar Ventures, Citi, Lux Capital, JAM Fund

Frequently asked about mPharma funding

How much has mPharma raised?: mPharma has raised $95M in total disclosed funding across the rounds on record.
Who has invested in mPharma?: Novastar Ventures, Citi, Lux Capital, JAM Fund are named among the investors backing mPharma.
What was the latest mPharma funding round?: The most recent disclosed round is a Series D, announced in January 2022.
Where is mPharma based?: mPharma is based in Accra, Ghana.
When did mPharma last raise?: The last disclosed mPharma round closed in January 2022 at Series D.

Every mPharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Accra at a similar stage.

mPharma Funding: $95M Raised, Series D (2022)

mPharma funding overview

mPharma at a glance

Frequently asked about mPharma funding

Companies related to mPharma (39)

Browse related funding lists (5)